Weekly Psychedelic Links, Monthly Psychedelic Recaps, Yearly Psychedelic Recaps, Announcements, Blog Information
David Wilder
The Roundups and Recaps Are Ending
The Roundups and Recaps Are Ending
Monthly Psychedelic Recaps
David Wilder
This Month in Psychedelics - December 2022
This Month in Psychedelics - December 2022
Weekly Psychedelic Links
David Wilder
Weekly Psychedelic Links - December 2022
Weekly Psychedelic Links - December 2022
Monthly Psychedelic Recaps
David Wilder
This Month in Psychedelics - November 2022
This Month in Psychedelics - November 2022
Weekly Psychedelic Links
David Wilder
Weekly Psychedelic Links - November 2022
Weekly Psychedelic Links - November 2022

music

Weekly Psychedelic Links - December 2022

12.2.22

Cannabis

  • Biden Signs Marijuana Research Bill, A Historic First For Federal Cannabis Reform (Marijuana Moment)

  • Idaho Plans for Medical Cannabis Legalization on the Ballot in 2024 (High Times)

  • Ohio Senate Votes To Remove Marijuana Paraphernalia Convictions From Criminal Records And Allow Broader Expungement (Marijuana Moment)

  • Police in India Say Rats Ate More Than 1,100 Pounds of Confiscated Weed (High Times)

  • Young Americans Are Twice As Likely To Smoke Marijuana Than Cigarettes, New Gallup Data Shows (Marijuana Moment)

  • New Federal Job Applications Won’t Ask About Most Marijuana Use Unless It Was Within The Past 90 Days (Marijuana Moment)

  • Many People with Bipolar Disorder Use Cannabis. It May Sometimes Help (Scientific American)

  • University Researchers Exploring Cannabis As A Treatment For Covid-19 (Forbes)

  • New York’s illicit weed products are weak and full of toxins, study finds (Leafly)

  • Medical Marijuana Legalization Linked To Reduced Opioid Use By Cancer Patients, American Medical Association Study Finds (Marijuana Moment)

  • Pennsylvania Starts Program Providing Financial Assistance to Low-Income Cannabis Patients (High Times)

  • Wedding Guest Files Lawsuit Over Pot-Infused Reception Food (High Times)

  • These States Almost Legalized Marijuana In 2022 (Marijuana Moment)

LSD

  • Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI (Psychedelic Science Review)

  • Former CEO Sues Company That Fired Him for Microdosing LSD in an Investor Meeting (Futurism)

Magic Mushrooms

  • DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn (Marijuana Moment)

  • Non-profit Organization Marches on Canadian Capital To Fight for Therapeutic Mushrooms (High Times)

MDMA

  • The man who took 40,000 ecstasy pills (The Face)

  • Climate Lessons from Cambodia’s Illegal MDMA Market (TalkingDrugs)

Ayahuasca

  • Why Ayahuasca Is Miley Cyrus' 'Favorite' Drug (And How It Supported Her Veganism) (Benzinga)

  • After closing its doors in Canterbury, a church serving hallucinogenic tea vows to reopen elsewhere (NHPR)

  • Ceremonial Ayahuasca in Amazonian Retreats: Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study (Chacruna)

Synthetic Cannabinoids

  • Prison “K2”: The Hidden Center of a Chaotic New Drug War (Filter)

Ketamine

  • Laid-off workers can now get a free month of ketamine-assisted therapy services to help with their mental health (Fortune)

  • Low-dose ketamine may reduce shivering following spinal anesthesia (Physicians Weekly)

  • Ketamine for Depression Poses “Significant Risk to the Public” (Mad in America)

  • Study shows how ketamine administration starkly changes neuronal activity patterns in the brain (News-Medical.net)

Miscellaneous

  • Berkeley, California Officials Approve Psychedelics Decriminalization Resolution Amid Pushback From Reform Advocates (Marijuana Moment)

  • Colombian And Mexican Presidents Announce International Effort To Reshape Drug Policy, Condemning ‘Failure’ Of Prohibition (Marijuana Moment)

  • Colorado Governor To Appoint Psychedelics Advisory Panel After Voters Approve Legalization Ballot Measure (Marijuana Moment)

  • Why the “Psychedelic Renaissance” is just Colonialism by Another Name (DoubleBlind)

  • Could the Latest Science on Psychedelics Revolutionise the Way We Understand Our Minds? (Men's Health)

12.9.22

Cannabis

  • Brittney Griner released from Russian detention in prisoner swap (Leafly)

  • Legalization Amendment To Be Added to Missouri Constitution (High Times)

  • New Jersey Marijuana Regulators Approve Rules For Public Cannabis Consumption Areas (Marijuana Moment)

  • Colombian Senate Approves Marijuana Legalization Bill, Bringing Country Closer To Ending Prohibition (Marijuana Moment)

  • Study: Cannabis Has ‘Uniquely Beneficial Effects’ on People With Bipolar Disorder (High Times)

  • Pain relief from marijuana comes from a belief it helps, study finds (CNN)

  • Delivery is in the works for New York’s new legal weed stores (Leafly)

  • Children are ditching alcohol for marijuana, as 20-year national US study shows a 245% increase (EurekAlert!)

  • Oregon recalls thousands of cannabis products over pesticide concerns (Marijuana Business Daily)

  • Minnesota Files Lawsuit Against Several Companies for Illicit Edible Sales (High Times)

  • As Congress Stalls On Marijuana Banking, New Report Details Public Safety Risk Of Cash-Intensive Dispensaries (Marijuana Moment)

  • NORML Report Highlights Citywide Policies Depenalizing Marijuana Law Enforcement (NORML)

  • Study: ‘Significant’ negative association between medical cannabis sales, alcohol (Marijuana Business Daily)

  • Dispensaries’ Cashless ATM Transactions Get The Ax (High Times)

  • Connecticut: Governor Announces Intent to Expunge 40,000+ Marijuana-Related Convictions (NORML)

  • Biden’s Health Secretary Shares Marijuana Scheduling News At 4:20—Again (Marijuana Moment)

  • Marijuana packaging rebrands can draw consumers, create cohesion, reflect values (Marijuana Business Daily)

  • Trend Sees Brands Pairing Top-Shelf Weed, Fine Dining (High Times)

LSD

  • Study on LSD microdosing uncovers neuropsychological mechanisms that could underlie anti-depressant effects (PsyPost)

Magic Mushrooms

  • Portlanders Explain Why They’re Waiting in Line for Psychedelic Mushrooms (Willamette Week)

  • Study suggests psilocybin increases mindfulness, especially when accompanied by mystical experiences (PsyPost)

  • Amsterdam’s Last Shroom Lounge (DoubleBlind)

  • Diamond Therapeutics completes Phase I clinical study of low-dose psilocybin in healthy human subjects (PR Newswire)

  • Oregon store allegedly selling psychedelic mushrooms raided (The Seattle Times)

MDMA

  • MDMA may be available for medical treatment "as soon as 2024" in US hospitals (Mixmag)

  • Wastewater data shows 286% increase in ecstasy use during pandemic (Healio)

  • Abuse Potential: Considerations for Rescheduling MDMA and Psychedelics (Psychedelic Science Review)

DMT

Ayahuasca

  • A Canadian psychedelic drug company has created medical grade ayahuasca (Toronto Star)

  • Modulatory Effects of Ayahuasca on Personality Structure in a Traditional Framework (Chacruna)

  • Declaration of The 4th Brazilian Indigenous Ayahuasca Conference (Chacruna)

Ketamine

  • Now Companies Can Buy Insurance To Cover Ketamine Therapy for Employees (Lucid News)

  • Using Ketamine to Treat Anorexia (Psychology Today)

  • Meta-Analysis of Intravenous vs Intranasal Ketamine (Psychiatric Times)

  • Low-dose Ketamine Effective In Reducing The Incidence Of Shivering Following Spinal Anesthesia (Medical Dialogues)

Miscellaneous

  • MAPS Found Liable in Wrongful Death Lawsuit (Lucid News)

  • Most States Will Legalize Psychedelics By 2037, Analysis Published By American Medical Association Predicts (Marijuana Moment)

  • When virtual reality meets psychedelic therapy (Mashable)

  • How Will Our Value Systems Affect The Psychedelic Movement? (Maps of the Mind)

  • We’re rushing the use of psychedelics as medicine, researchers say (New Scientist)

  • Awakn Makes Its Case To Investors (Lucid News)

  • Punk Ethos & Psychedelic Practice (Maps of the Mind)

12.16.22

Cannabis

  • Recreational Weed Now Legal in Missouri (High Times)

  • Connecticut: Adult-Use Cannabis Sales to Begin Next Month (NORML)

  • New Hampshire GOP And Democratic House Leaders Team Up On Marijuana Legalization Bill For 2023 (Marijuana Moment)

  • Here’s how New York’s legal weed delivery will work (Leafly)

  • Teen Marijuana Use Remained Stable In 2022, Despite More States Legalizing And Lifting Of Pandemic Restrictions (Marijuana Moment)

  • Kansas City: Officials Dismiss Hundreds of Marijuana Cases Following Statewide Legalization Vote (NORML)

  • Kansas Lawmakers Plan To Introduce Medical Cannabis Legalization Bill (High Times)

  • Prosecution collapses against execs caught up in CannTrust cannabis scandal (CBC)

  • Texas Activists Turn In Signatures To Put Marijuana Decriminalization Back In Voters’ Hands After City Council Repeal (Marijuana Moment)

  • Massachusetts To Add Lessons on Weed Impairment to Driver’s Ed (High Times)

  • Nearly 2 Million Marijuana Convictions Have Been Pardoned Or Expunged In The U.S. In The Past Five Years, New Report Shows (Marijuana Moment)

  • Australian Residents Could Save $850 Million Annually if Cannabis is Decriminalized (High Times)

  • Marijuana Legalization Reduces Arrests Even In States That Already Decriminalized, American Medical Association Study Finds (Marijuana Moment)

LSD

  • Up to 9% of LSD and psilocybin users report reoccurring effects after drug has worn off (PsyPost)

  • Gut Feeling: Links Between LSD, Endocannabinoids, and the Microbiome (Psychedelic Science Review)

Magic Mushrooms

  • Florida halts amanita muscaria sales at nation’s only brick-and-mortar retailer (Leafly)

  • COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP (Psychedelic Alpha)

  • Here’s why police are raiding psychedelic mushroom stores in major cities (Leafly)

  • Rat Study Examines Psilocybin as Treatment for Autism Spectrum Disorder (High Times)

MDMA

  • The History and Benefits of MDMA, the New Tool in Mental Health Again (Daily Kos)

DMT

  • Experiencing a Changa Ceremony at an Oakland Plant Medicine Church (Lucid News)

Ayahuasca

  • Aaron Rodgers says doing psychedelic drug ayahuasca helped him overcome his ‘fear of death’ (The Independent)

5-MeO-DMT

  • UCL To Lead First-Ever Brain Imaging Study Among Psychedelic Retreat Participants (High Times)

  • PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert Toad as it Files Three New Provisional Patent Applications, Including Intellectual Property Protection for the Biosynthetic Production of 5-MeO-DMT (Psychedelic Alpha)

Peyote

  • Inside the battle to save the sacred peyote ceremony: ‘We’re in dire straits’ (The Guardian)

Novel Psychoactive Substances

  • Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100 (Psychedelic Alpha)

Ketamine

  • Ketamine plus therapy could help treat alcoholism, say researchers (The Guardian)

Miscellaneous

  • Verdict in Lawsuit Assigns MAPS 25% Liability and $1M in Damages (Lucid News)

  • New center takes multidisciplinary approach to the study of psychedelics (University of Michigan)

  • It’s Not Just About Pot. Our Entire Drug Policy Needs an Overhaul. (The New York Times)

  • The Effects of Sleep Deprivation on a Psychedelic Experience (Sam Woolfe)

  • Would You Be Friends With Your Friends if You Didn’t Do Drugs Together? (VICE)

  • Why is Gender-Affirming Care Needed in the Psychedelic Space? (Chacruna)

  • How Many Likes Does it Take to be a Psychedelic Thought Leader? (Lucid News)

12.23.22

Cannabis

  • First words from Brittney Griner: Thanks Biden, vows to help free others (Leafly)

  • Federally Funded Study Finds Teen Use Rates Largely Unchanged by Legalization (NORML)

  • Canada Destroys a Record Amount of Cannabis (High Times)

  • District of Columbia: Council Members Advance Legislation to Expunge Tens of Thousands of Marijuana Convictions (NORML)

  • Afroman Announces 2024 Run for President (High Times)

  • Twitter Stops Suggesting People Who Search For ‘Marijuana’ May Need Drug Treatment (Marijuana Moment)

  • Canada’s Cannabis Legalization Is Working Effectively, Annual Survey Suggests (Forbes)

  • New Washington Bill Would Allow Interstate Marijuana Commerce (Marijuana Moment)

  • New Report Analyzes Medical Pot Patients’ Consumption Habits (High Times)

  • Majority Of Texas Voters Back Marijuana Legalization, And Three In Four Support Decriminalization, Poll Finds (Marijuana Moment)

LSD

  • How LSD evolved from CIA mind-control drug to counterculture emblem (Leafly)

Magic Mushrooms

  • Quebec covers psilocybin therapy under medical insurance in historic first (Leafly)

  • Oregon Psilocybin Entrepreneurs Navigate Business Requirements (Lucid News)

Ayahuasca

  • Canadian Company Announces Ayahuasca Pills (Chacruna)

  • Music and ayahuasca’s role in treating substance use disorders in men (UC Riverside)

Datura

  • Weed responsible for hallucinogenic spinach recall identified as thornapple (The Guardian)

Miscellaneous

  • New Bill Tries to Decriminalize Psychedelics in California—Again (DoubleBlind)

  • The Myth of the Psychedelic Santa (Lucid News)

  • U.K. Police Chiefs Call for Decriminalization of First-Time Drug Offenses (High Times)

  • Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute (Psychedelic Alpha)

  • Placebo Problems: Boundary Works in the Psychedelic Science Renaissance (Chacruna)

12.30.22

Cannabis

  • Record Number of Scientific Papers Published About Cannabis in 2022 (NORML)

  • Washington, D.C. Passes Bill To Expand Medical Weed Sales (High Times)

  • Google Ends Ban On Advertising Certain Hemp And CBD Products In Parts Of U.S. (Marijuana Moment)

  • Clinical Trial Finds Cannabis Oil is Well-Tolerated, Effective Insomnia Treatment (High Times)

  • Snoop Dogg’s Death Row Records To Launch Its Own Cannabis Brand (Forbes)

  • California Gov. Gavin Newsom Pardons 10, Some Cannabis Convictions (High Times)

  • A dying US cancer patient used cannabis to ease pain. His hospital called the police (The Guardian)

  • South Dakota Activists File Measure That Could Put Marijuana Legalization On Ballot For Third Election In A Row (Marijuana Moment)

  • Is legal weed doomed to be run by big business? (Vox)

  • Texas Marijuana Activists Submit Enough Signatures To Challenge Local Decriminalization Repeal, While Another City’s Reform Faces Lawsuit (Marijuana Moment)

Magic Mushrooms

  • A single dose of psilocybin improves depression in treatment-resistant patients, but with adverse effects (PsyPost)

  • Psilocybin Therapy For Autism-Like Disorder Receives Approval For Phase 2a Clinical Trial (The Dales Report)

  • Do Shrooms Go Bad? (DoubleBlind)

MDMA

  • MDMA Is Getting Super Popular Among Rich, Young Indians (VICE)

  • VA Report Says Psilocybin And MDMA Show Therapeutic ‘Promise’ For Veterans’ Mental Health Conditions (Marijuana Moment)

DMT

  • Phase 2a study initiated to examine synthetic DMT for treatment-resistant depression (Healio)

Ayahuasca

  • “Nobody Wants A Synthetic-Only Future”: Filament Health Is Formulating Natural Psilocybin And Standardizing Ayahuasca (Healing Maps)

Novel Psychoactive Substances

  • Tripping Without The Trip: Non-Hallucinogenic Psychedelics (Benzinga)

Ketamine

  • Much remains unknown about using ketamine to treat depression—and Colorado doesn't regulate it (The Denver Post)

Miscellaneous

  • New York Lawmakers File Psychedelics Legalization Bill For 2023 (Marijuana Moment)

  • Psychedelics Like Psilocybin Are Now Legal In Colorado With Governor’s Proclamation On Voter-Approved Ballot Measure (Marijuana Moment)

  • The Multidimensional Worlds of Mariela de la Paz (DoubleBlind)

  • Minnesota Medical Association Endorses Decriminalizing Drugs (Marijuana Moment)

  • Psychedelic therapies are on the horizon, but who will administer the drugs? (NBC News)

  • Psychedelic drugs may launch a new era in psychiatric treatment, brain scientists say (NPR)

  • Psychedelics Are Surging—at the Expense of Indigenous Communities (The Daily Beast)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Weekly Psychedelic Links - October 2022

10.7.22

Cannabis

  • Biden Announces Mass Marijuana Pardons And Calls For Cannabis Scheduling Review (Marijuana Moment)

  • Amsterdam considers banning ‘cannabis tourists’ from its coffee shops (The Guardian)

  • Costa Rica’s President Sends Marijuana Legalization Bill To Lawmakers (Marijuana Moment)

  • 'It's like the new Amsterdam': The rush to cash in on Thailand's hazy cannabis laws (Australian Broadcasting Corporation)

  • FBI: Nearly Half of All Drug Seizures in 2021 Involved Marijuana (NORML)

  • Morocco issues first permits for cannabis production (Reuters)

  • Committee in Colombia Approved Adult-Use Legalization Proposal (High Times)

  • Most Americans Don’t Think Marijuana Is Dangerous Despite Prohibitionist Arguments, Poll Finds (Marijuana Moment)

  • Regulators finally approve hempcrete for US homes (Leafly)

  • OSHA report ties cannabis worker death to dust inhalation (Leafly)

  • Survey: Medical Students Rarely Exposed to Scientific Data About Cannabis (NORML)

Magic Mushrooms

  • Oregon enters the home stretch to authorize psilocybin mushrooms (Chacruna)

  • This 'magic' mushroom dispensary in Florida is selling psychedelics and testing legal boundaries (Business Insider)

MDMA

  • MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA (Psychedelic Alpha)

DMT

Ayahuasca

Novel Psychoactive Substances

  • These LSD-based drugs seem to help mice with anxiety and depression — without the trip (NPR)

  • Are you too high? A promising new ‘comedown drug’ may be on the way (Leafly)

Synthetic Cannabinoids

  • Unexplained Bleeding Linked to Rat Poison in Synthetic Cannabinoids (Medpage Today)

Nitrous Oxide

  • Nitrous oxide: Southend mum's campaign over 'laughing gas' (BBC)

Ketamine

  • Ketamine and depression: A mechanism of the antidepressant revealed (Medical Xpress)

  • PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s Disease (Psychedelic Alpha)

Miscellaneous

  • Alberta to be 1st province to regulate psychedelics for therapy, government says (CBC)

  • DEA Admits ‘Racial, Ethnic and Class Prejudice’ Led To Drug Criminalization And The Agency’s Own Founding (Marijuana Moment)

  • New York Lawmakers File Amended Psychedelics Legalization Bill, With New Regulations And Protections (Marijuana Moment)

  • Psychedelics may flatten your brain’s landscape, but in a good way (Leafly)

  • Inflammation Nation: How Psychedelics Could Combat Widespread Chronic Pain (Psychedelics Today)

  • Psychedelics: Will Policy Liberalization and Lower Barriers to Access Lead to Future Legalization? (Lexpert)

  • Psychedelics are exploding in the startup community as founders say it makes them better leaders (Fortune)

  • Timothy Leary’s psychedelic eugenics (Medium)

  • Eleusis Holdings Plans To Be Acquired By Beckley Psytech (Lucid News)

  • ‘Bad’ Psychedelic Trips Don’t Have To Be Bad (VICE)

10.14.22

Cannabis

  • Colombian Chamber Of Representatives Passes Marijuana Legalization Bill In Initial Vote, With Support From Cabinet Ministers (Marijuana Moment)

  • U.S. Air Force to Allow Applicants to Retest After Positive THC Test (High Times)

  • Why bees love weed — and why it might even be good for them (Salon)

  • Cannabis Stock’s Post Pardon Depression Could Be Cured By Lame Duck Legislation (Forbes)

  • New Study Shows Cannabis Users More Likely To Have Overactive Bladders (High Times)

  • Federal Reserve Bank Says Marijuana Legalization Drives Tax Revenue, Job Creation And Real Estate Sales (Marijuana Moment)

  • Spliff Vape: New Tech Allows Cannabis, Nicotine To Be Vaped Simultaneously (High Times)

Magic Mushrooms

  • Flight Passenger on Mushrooms Causes Chaos Mid-Flight (High Times)

  • Can Psilocybin Challenge Our Pharmaceutical Dependence? (Vogue)

MDMA

  • Eels Living Near Music Festivals Test Positive For MDMA And Cocaine (IFLScience)

Synthetic Cannabinoids

  • Synthetic Marijuana In Florida Tainted With Rat Poison, 52 Sick, 4 Dead (Forbes)

  • Five-Year-Old Missouri Child Gets Delta-8 Edibles in Halloween Bag (High Times)

Nitrous Oxide

  • Nitrous Oxide: Harm Reduction and the Muslim Community (VolteFace)

Miscellaneous

  • These States Are Voting On Marijuana And Psychedelics Legalization On Their November Ballots (Marijuana Moment)

  • Elon Musk reportedly goes on 'exploratory journeys' and likes to show friends a chart of the benefits of MDMA and mushrooms over alcohol (Business Insider)

  • To Standardize Psychedelic Therapy, A New Organization Launches (Forbes)

  • Horizons Conference Returns to NYC for Its 15th Year (Lucid News)

  • Treating postpartum depression with psychedelics (The Print)

  • A Santo Daime Church’s Legal Success Paved a Path Towards Psychedelic Legalization (Lucid News)

  • Instagram’s Page-Deletions of Black Women in Psychedelic Advocacy (Filter)

  • Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3 (Psychedelic Spotlight)

  • What Made María Sabina Unique (DoubleBlind)

  • The Politics of Psychedelics: Legalisation vs Decriminalisation (Sam Woolfe)

10.21.22

Cannabis

  • German cannabis legalisation plans LEAKED (VolteFace)

  • Washington DC lets tourists self-certify for medical cannabis (Leafly)

  • Poll: Two-Thirds of Voters Say “Nobody Should Be in Jail” for Marijuana Possession (NORML)

  • States With the Most Arrests for Marijuana Possession (U.S. News and World Report)

  • Why does marijuana make it hard to remember stuff? (Salon)

  • NBA Won’t Test Players For Marijuana For Third Season In A Row, Report Says (Marijuana Moment)

  • Nearly Four Out of Five Patients Drop or Reduce Opioids After Using Medical Weed (High Times)

  • Brazilian Federal Council of Medicine Bans CBD Prescriptions for Adult Patients (TalkingDrugs)

  • Cannabis Had Highest Tax Revenue in Colorado and Washington Over Alcohol, Cigarettes (High Times)

  • Marijuana was illegal 4 years ago. Now, Uber Eats delivers it in Toronto (CBC)

  • Missouri Police Object To New Ad For Marijuana Legalization Ballot Initiative That Shows Officers (Marijuana Moment)

  • Oklahoma Governor Sets March Special Election for Weed Legalization Initiative (High Times)

  • Texas Activists Unveil Marijuana Decriminalization, Police Reform And Abortion Rights Initiative For San Antonio 2023 Ballot (Marijuana Moment)

  • Puerto Rico Bill Would Expunge Low-Level Weed Possession Convictions (High Times)

LSD

Magic Mushrooms

  • Oregon is voting on medical psilocybin, again (Leafly)

  • NYC smoke shops are selling magic mushroom candy bars (New York Post)

  • Study To Examine Why Shrooms Evolved with Psychedelic Properties (High Times)

  • Why Everyone Cares So Much About Colorado’s Psilocybin Bill (DoubleBlind)

MDMA

  • MDMA-assisted psychotherapy shows promise in the treatment of eating disorder symptoms (PsyPost)

5-MeO-DMT

  • The toad boom: the false narrative of ancestral 5-MeO-DMT use (Points)

Novel Psychoactive Substances

  • Scientists Discover ‘Disconcerting’ New Imitation Ketamine on the Market (VICE)

Synthetic Cannabinoids

Ketamine

  • Ketamine May Reduce Suicidal Ideation in Treatment-Resistant Depression (Psychiatry Advisor)

Miscellaneous

  • Australian Lawmakers Approve Drug Decriminalization Bill For Federal Territory That Includes Nation’s Capital (Marijuana Moment)

  • DEA Proposes Dramatic Increases In Marijuana And Psychedelics Production In 2023 For Research (Marijuana Moment)

  • Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development (PsyPost)

  • Will Medical Insurers Agree to Cover Psychedelic Trips? (Bloomberg)

  • Why is the American right suddenly so interested in psychedelic drugs? (The Guardian)

  • Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio (Psychedelic Alpha)

10.28.22

Cannabis

  • Germany’s Government Approves Marijuana Legalization Plan, But Reform Depends On European Union Sign-Off (Marijuana Moment)

  • Russian court upholds Brittney Griner’s sentence (Leafly)

  • Biden's Marijuana Pardons Did Not Free a Single Federal Prisoner or Deliver the Expungement He Promised (Reason)

  • Activist Arrested At White House Protest Pushing Biden To Release Marijuana Prisoners (Marijuana Moment)

  • Missouri’s legalization measure is drawing unexpected opposition (Leafly)

  • Five States To Vote on Recreational Cannabis This Election Season (High Times)

  • Most Americans Say Alcohol And Tobacco Are More Dangerous Than Marijuana, Poll Finds (Marijuana Moment)

  • California Lawsuit Alleges Weed Didn't Get Plaintiffs High Enough (VICE)

  • Research: Does Cannabis Really Make You More Creative? (Harvard Business Review)

  • Israeli Company Clones Cannabis Cells—Not Plants—With Up to 12 Times the Potency (High Times)

  • It's not a myth: Marijuana really is more potent than it used to be (Salon)

  • Study: Cannabis Use Not A Risk Factor in Liver Transplants (High Times)

  • Strange Bedfellows Team Up To Oppose Missouri Marijuana Legalization Ballot Measure (Marijuana Moment)

  • Research Shows Cannabis Users Experience More Pain After Surgery (High Times)

  • Support For Arkansas Marijuana Legalization Initiative Falls To Slim Majority As GOP Lawmakers Urge Opposition, Poll Finds (Marijuana Moment)

  • How does THC affect prenatal development? (Leafly)

Magic Mushrooms

  • The world's first Phase 3 psilocybin clinical trial is about to commence (New Atlas)

  • DEA Faces New Legal Challenges Over Denying Psilocybin Rescheduling Petition And Doctor’s Federal Waiver Request (Marijuana Moment)

  • New Study Will Explore Psilocybin as a Treatment To Stop Smoking (High Times)

  • N.S. company launching clinical trial to examine magic mushrooms as treatment for PTSD (CBC)

  • The Potential Health Benefits of Microdosing Psilocybin With Chocolate (Psychology Today)

  • Psilocybin Common Denominator in Several Recent Albums (High Times)

DMT

  • Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study (Psychedelic Alpha)

Ayahuasca

Peyote

  • Native American Church Asks Congress for Peyote Funding (DoubleBlind)

Novel Psychoactive Substances

  • WTF is 3-MMC, Berlin’s Weird New Club Drug? (DoubleBlind)

  • Electric Picnic drug testing finds 'new psychoactive substances' never seen before in Ireland (The Irish Mirror)

Synthetic Cannabinoids

  • Utah Medical Cannabis Flooded With Synthetic Cannabinoids From Hot Hemp (Forbes)

Ketamine

  • Electroconvulsive Therapy Could Be Better Than Ketamine At Treating Depression (IFLScience)

Miscellaneous

  • Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited (Psychedelic Alpha)

  • People Who Use Psychedelics Are More Connected To Nature And Knowledgeable About Climate Change, Study Finds (Marijuana Moment)

  • Use of Psychedelic Therapies for Treatment Resistant Patients Again Rejected by Government, Despite Strong Supporting Safety and Efficacy Data and Australia’s Worsening Mental Health Crisis (Mind Medicine Australia)

  • With Promise of Legalization, Psychedelic Companies Joust Over Future Profits (The New York Times)

  • Manipulating light can induce psychedelic experiences – and scientists aren’t quite sure why (The Conversation)

  • The ideological war at the heart of the psychedelic renaissance (New Atlas)

  • Research, remedy and regulation: the changing dynamics of psychedelic therapy in Alberta (CBC)

  • An Exploration of Psychedelics and Creativity (Drug Science)

  • Variants in 5-HT2A Receptor Gene Alter Psychedelic Pharmacology (Psychedelic Science Review)

  • Guidelines for Ethical Sponsorship and Transparency in Psychedelic Conferences (Chacruna)

  • Terence McKenna's secret bad trip (Ecstatic Integration)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.11.22

Cannabis

  • South Carolina Medical Marijuana Legalization Bill Officially Approved In Senate, Heads For House Consideration (Marijuana Moment)

  • Maryland Lawmakers Introduce Adult-Use Cannabis Legalization Bill (High Times)

  • UK trial of medical cannabis and long covid to get underway this month (Cannabis Health News)

  • The Super Bowl won’t be lit: no cannabis ads allowed (The Verge)

  • Bill Introduced to Raise THC Limit in Hemp to One Percent (High Times)

  • Cannabis Store Co-owned By Top Virginia Senator Sells Mislabeled Products With Illegal THC Content, Media Investigation Finds (Marijuana Moment)

  • Study Shreds Cannabis ‘Amotivational Syndrome’ Theory (High Times)

  • Flower still king of US marijuana market, though supremacy waning (Marijuana Business Daily)

  • Oklahoma Becomes Marijuana Legalization Battleground Between Advocates, With Legal Challenges And A New Ballot Initiative (Marijuana Moment)

  • New York Cracks Down on Illegal Cannabis Businesses (High Times)

  • Missouri Supreme Court Unanimously Orders Medical Marijuana Applicant Disclosures (Marijuana Moment)

  • Pennsylvania Senate committee holds first-ever hearing on legalizing recreational marijuana (WGAL)

  • Police Seizure Of Marijuana Dispensary Cash Leads To Federal Litigation (Marijuana Moment)

  • Cannabis platform Leafly closes merger with SPAC, goes public on Nasdaq (Marijuana Business Daily)

  • The Eternal Pricing Struggle of UK Medical Cannabis Patients (TalkingDrugs)

  • Weedmaps Ad Satirizes Plight Of Broccoli Emoji As Marijuana Stand-In On Social Media (Marijuana Moment)

  • Young cannabis users at increased risk of repeat stroke (Medical News Today)

  • Federally Owned Utility Company Walks Back Threat To Block Electricity For Marijuana Businesses (Marijuana Moment)

  • Cali Vibes Rocks Long Beach, Allowing Cannabis (High Times)

  • How does cannabis use affect brain health? Caution advised, more research needed, experts say (ScienceDaily)

LSD

  • Microdose Psychedelics Presents a Molecular Masterclass: The LSD Conference (GlobeNewswire)

Magic Mushrooms

  • Psilocybin microdosing does not reduce symptoms of depression or anxiety, according to placebo-controlled study (PsyPost)

  • Lawmakers say no to bill legalizing psilocybin-assisted therapy in Maine (The Portland Press Herald)

  • Oregon proposes only using one type of mushroom for new psilocybin system, and no pills (OPB)

  • More States Follow Oregon’s Lead Toward Legal Psilocybin Therapy (Lucid News)

  • Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs (Business Wire)

  • Maine CDC Director Opposes Bill to Legalize Therapeutic Psilocybin (Psychedelic Spotlight)

  • The Many Types of Psychedelic Mushrooms (Truffle Report)

  • Mazatec Shamanic Knowledge and Psilocybin Mushrooms (Chacruna)

MDMA

DMT

Ayahuasca

  • Creating Awareness on Sexual Abuse in Ayahuasca Communities: A Review of Chacruna’s Guidelines (Chacruna)

5-MeO-DMT

  • Scientists Create Cell-Based Psychedelic Toad Venom, a Potential 5-MeO-DMT “Bio-Factory” (Lucid News)

Mescaline

Iboga

  • Osoyoos Indian Band eyes cutting-edge drug treatment centre (Vancouver Sun)

Novel Psychoactive Substances

  • Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of Anxiety Disorders (Psilocybin Alpha)

Nitrous Oxide

  • Another new weapon to beat Corona, first 'nasal spray' launched in India (News Track)

  • Nitrous Oxide Safe For Dental Procedures In Children With Sickle Cell Disease: Study (Medical Dialogues)

Ketamine

  • Ketamine effectively silences suicidal thoughts, especially in bipolar patients (Study Finds)

  • Researching Ketamine for Social Anxiety Disorder (Truffle Report)

  • Yale researcher receives grant to study effects of ketamine in individuals with epilepsy (Yale Daily News)

  • Trip Tunes: A Conversation with Producer Jon Hopkins About Making Music for Ketamine (DoubleBlind)

  • Ketamine Infusions in the Home May Facilitate Safe Treatment Access During the Pandemic (Pharmacy Times)

Miscellaneous

  • Can microdosing psychedelics boost mental health? Here’s what the evidence suggests. (National Geographic)

  • Utah House Overwhelmingly Approves Psychedelics Study Task Force Bill (Marijuana Moment)

  • Maryland Senate Bill Would Provide ‘Cost-Free Access’ To Psychedelics For Military Veterans (Marijuana Moment)

  • Psychedelics Offer New Route to Recovery from Eating Disorders (NEO.LIFE)

  • Are Psychedelics the Future of Pain Relief? (VICE)

  • Michigan Activists Submit Psychedelics Decriminalization Language (High Times)

  • DEA Faces Backlash Over Proposed Scheduling Of Five Psychedelic Compounds (Marijuana Moment)

  • Proposed Drug-Decrim Ballot Initiative All Set in Washington State (Filter)

  • Can Psychedelics Make People More Drawn to Conspiracy Theories? (Sam Woolfe)

  • Yes, Psychedelics Do Change Our Metaphysical Beliefs (DoubleBlind)

  • Panel Discusses Coalition Building to Unlock Therapeutic Effects of Psychedelics (The Yale School)

  • Legal Psychedelics: The U.S. Cities Where Psilocybin, LSD And Others Are Decriminalized (Healing Maps)

  • Canada’s Reforms on Psychedelics Are Slowly Taking Shape (Bloomberg)

  • Survey Shows 65% of Affected Americans Want Access to Psychedelic Treatments for Mental Health Conditions (Pharmacy Times)

  • New Polling by Mind Medicine Australia Reveals Over 60% of Australians Support Increased Access to Psychedelic Medicines (Mind Medicine Australia)

  • Big Pharma In Psychedelics: Inside Mindset Pharma’s Deal With Otsuka (Forbes)

  • Using Real-World Evidence to Accelerate Psychedelic Drug Development (Truffle Report)

  • Is city getting ‘high’ on hallucinating drugs? (The Hindu)

  • Drug Euphoria Is a Good Thing, Actually (Filter)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Year in Psychedelics - 2021

Before we get into this recap of the biggest psychedelic news stories from 2021, I’d like to address the fact that this blog post is coming out a month late. Normally I strive to publish my yearly recaps on New Year’s Eve, but things have been really hectic on my end lately and I’ve been barely keeping up with putting out the weekly link roundups, much less creating monthly and yearly recaps or other types of content.

So I apologize for not getting this out into the world sooner. I’ve started to realize that I bit off way more than I can chew over the last year and fell behind on things here at Think Wilder. Here’s hoping 2022 will be a little more focused so I can meet my deadlines and get my work out in a timely manner for y’all to enjoy!

Just like last month’s recap, there is no video recap of this year’s psychedelic news recap up on YouTube. I’ll have another update about some changes coming to my YouTube channel that should hopefully be out later this week on my channel, so make sure you subscribe there if you’d like to be informed about things on that front.

Moving on to the main show, there was a ton of huge news in 2021. Without further ado, let’s jump into the news.

Policy

Wins

Nine U.S. cities decriminalized psychedelics:

When it comes to cannabis policies there were several successes at the state level, even though attempts to change things at the federal level were unsuccessful. Four states legalized weed:

In addition, Alabama legalized medical marijuana and New Jersey and Louisiana decriminalized cannabis.

Taking things a bit further, Baltimore, MD and Scotland decriminalized the use of all drugs.

The governors of Connecticut and Texas signed legislation that will enable the states to study the therapeutic potential of psychedelics. And New Zealand legalized drug checking, becoming the world’s first country to do so.

Industry

One of the biggest stories in the psychedelic industry involved the fight over patenting various aspects involving psychedelics. The one that probably stirred up the most discontent was when COMPASS Pathways submitted a patent application that attempted to claim the right to common, preexisting psychedelic therapy techniques. This prompted a discussion about patents in psychedelia, with many people wondering if companies should own the future of the field. COMPASS Pathways has five U.S. patents and a total of ten worldwide, so they are quickly claiming rights to a lot of intellectual property in the space. But not without a fight—last month a non-profit known as Freedom to Operate submitted a new legal filing that argues against COMPASS Pathways’ patent on its form of synthetic psilocybin based on the idea that it is not a novel invention. The results from this case will set a precedent for not just COMPASS Pathways but for other psychedelic companies as well.

Psychedelic companies started making waves on the stock markets around the world, with five companies joining the Nasdaq (Mindmed, atai Life Sciences, Field Trip Health, Enveric Biosciences, and Bright Minds Biosciences) and Cybin joining the New York Stock Exchange.

Psychedelic companies secured a historic amount of funding, estimated at a cool $2 billion.

A few other interesting stories in the realm of psychedelic industry from 2021:

Research

Published Studies

Several studies came out:

Future Studies

Looking ahead:

  • A study looking to treat tobacco addiction with psilocybin will receive federal funding

  • The NIH granted Yale nearly $200k to fund the studying of psilocybin for depression and obsessive-compulsive disorder

  • The Australian government earmarked $15 million for psychedelic research

  • The DEA has proposed a dramatic increase in the production of cannabis and psychedelics for research in 2022

Research Centers

A record-breaking number of psychedelic research centers were announced or opened:

In addition to these new psychedelic research centers, Harvard Law School’s Project on Psychedelics Law and Regulation will contribute to the effort to create evidence-based laws and policies involving psychedelics.

Harm Reduction

The FDA and CDC issued warnings to consumers about potential risks involving delta-8 THC, a relatively new psychoactive cannabinoid that has grown in popularity due to its widespread legality but remains essentially unregulated at this time. Apparently there has been a significant increase in reported adverse health effects from people using this drug.

However, before you go ahead and toss any of these products you may already own out of the window, it may be helpful to know that it’s not like people are getting poisoned. In fact, it’s far more likely that they are unintentionally getting high after using delta-8 THC because of misunderstandings, bad labeling, and a lack of experience.

The Fireside Project has been helping people process psychedelic experiences via its free peer support phone line since it launched last April, but the organization took things to the next level by releasing a psychedelic peer support app. Now psychonauts in need of support can find help on either the phone or via chat, which may be helpful for people who prefer one form of communication over another.

Drug checking is an essential practice for any responsible psychonaut, and new technologies are coming out that will ensure more innovative and accurate results than ever before. The popular harm reduction organization known as DanceSafe released a new ketamine test kit (called the Morris reagent) that was engineered to identify the difference between ketamine and common analogues like DCK and 2FDCK. And a startup called Miraculix took things one step further by creating rapid at-home test kits that can assess the potency of various psychoactive drugs, including MDMA, LSD, and psilocybin.

Harm reductionists have yet another tool that can be used to help psychonauts use drugs as safely as possible; a new app called Pill-iD lets users scan pills to see what they contain.

However, it’s not a perfect option because rather than find out what’s actually inside a pill, the app instead uses machine learning to cross-check the user’s image against a large database of scanned pills to provide details about what drug is actually contained within, the risk level from taking it, and any potential side effects.

So while it’s not advisable to rely solely on this new app to find out what’s inside your pill, it could help inform naïve users that there is a possibility they might have bought an adulterated drug. As I’ve tried to hammer home over and over again, it’s always advisable to use a reagent test kit to further rule out the possibility that your pills contain unwanted drugs and to properly weigh your substances before you take them.

Miscellaneous

What a year! Tons of new psychedelic research studies, a streak of drug policy reform wins, the growing psychedelic industry, and several important developments in psychedelic culture… last year was certainly a lot to take in.

Now that you’ve read my recap of the biggest psychedelic news from 2021, I’d like to recommend the following highlights from other publications that you might enjoy:

And lastly, I will leave you with the links to the annual psychedelic news recaps I’ve published over the last six years. I hope you have a wonderful 2022 and make sure you subscribe to my monthly newsletter to keep up-to-date with all the latest psychedelic news.

Previous Years in Psychedelics

That’s all for this year’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this year’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

This Week in Psychedelics - 11.19.21

Cannabis

  • U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

  • Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

  • Brazil is on The Brink of Medical Cannabis Change (High Times)

  • Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

  • Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

  • New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

  • Straws Lined with THC Could Transform Edibles Industry (High Times)

  • Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

  • New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

  • Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

  • Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

  • Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

  • Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

  • Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

  • Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

  • MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

  • Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

  • Is LSD Safe - Latest Research Findings (Drug Science)

  • The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

  • Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

  • NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

  • Magic Mushrooms, A Love Story (The New Yorker)

  • PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

  • Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

  • TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

  • Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

  • Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

  • World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

  • Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

  • Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

  • Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

  • Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

  • Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

  • Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

  • New Psychedelic Molecules: What’s in Development? (Truffle Report)

  • New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

  • Researchers train computers to predict the next designer drugs (ScienceDaily)

  • BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

  • Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

  • Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

  • Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

  • Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

  • Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

  • Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

  • "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

  • Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

  • Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

  • New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

  • Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

  • Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

  • Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

  • Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

  • Three Decades of Drug Policy Reform Work (Open Society Foundations)

  • A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

  • Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

  • A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

  • The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

  • Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

  • CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

  • MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

  • Letting people test their drugs will reduce the number of needless deaths (The Independent)

  • The History of Psychedelics: An ancient tradition (Canex)

  • MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.